AU2015903141A0 - Controlled release formulations of paracetamol - Google Patents

Controlled release formulations of paracetamol

Info

Publication number
AU2015903141A0
AU2015903141A0 AU2015903141A AU2015903141A AU2015903141A0 AU 2015903141 A0 AU2015903141 A0 AU 2015903141A0 AU 2015903141 A AU2015903141 A AU 2015903141A AU 2015903141 A AU2015903141 A AU 2015903141A AU 2015903141 A0 AU2015903141 A0 AU 2015903141A0
Authority
AU
Australia
Prior art keywords
paracetamol
controlled release
release formulations
formulations
controlled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2015903141A
Inventor
Subodh Chandra Das
S M. Rabbur Reza
Khalid Rafi
Md. Nadim Reza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beximco Pharmaceuticals Ltd
Original Assignee
Beximco Pharmaceuticals Ltd
Filing date
Publication date
Application filed by Beximco Pharmaceuticals Ltd filed Critical Beximco Pharmaceuticals Ltd
Publication of AU2015903141A0 publication Critical patent/AU2015903141A0/en
Priority to AU2016210691A priority Critical patent/AU2016210691A1/en
Abandoned legal-status Critical Current

Links

AU2015903141A 2015-08-05 2015-08-05 Controlled release formulations of paracetamol Abandoned AU2015903141A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2016210691A AU2016210691A1 (en) 2015-08-05 2016-08-04 Controlled release formulations of paracetamol

Publications (1)

Publication Number Publication Date
AU2015903141A0 true AU2015903141A0 (en) 2015-08-20

Family

ID=

Similar Documents

Publication Publication Date Title
IL280485A (en) Modified release formulations of pridopidine
EP3452003A4 (en) Controlled release dosage form
EP3377070A4 (en) Compounds and methods of their use
EP3160470A4 (en) Analogs of pridopidine, their preparation and use
EP3509581A4 (en) Formulations of (r
EP3373969A4 (en) Glycan-interacting compounds and methods of use
EP3193888A4 (en) Novel formulations
IL265856A (en) Formulations for administration of eflornithine
EP3193854A4 (en) Eutectic formulations of cyclobenzaprine hydrochloride
EP3174525A4 (en) Otic formulations for the treatment of ceruminosis
EP3384921A4 (en) New use of thiopeptin
EP3297619A4 (en) Therapeutic uses of l-4-chlorokynurenine
EP3237412A4 (en) Solid dispersion formulations of antiviral compounds
EP3394099A4 (en) Formulations of engineered anti-il-10 antibodies
EP3313520A4 (en) Therapeutic uses of berberine formulations
IL272857A (en) Formulations of copanlisib
EP3402463A4 (en) Formulations of vancomycin
EP3373928A4 (en) Novel formulations
EP3265177A4 (en) Formulations of hydrophilic compounds
EP3203992A4 (en) Compositions and methods for increasing the bioavailability of one or more compounds
EP3383947A4 (en) Release aid
EP3349853A4 (en) Prodrugs of fencamfamine
IL267279A (en) Pharmaceutical formulations of suvorexant
EP3338775A4 (en) Use of butylidenephthalide
PT3678644T (en) Formulations of copanlisib